All PlansAdministrativeLow impact
Voluntary nationwide recall: Clonazepam (Endo – November)
UPMC Health Plan·Neurology, Psychiatry, Family Medicine +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Endo USA has issued a voluntary nationwide recall of certain lots of Clonazepam Orally Disintegrating Tablets due to incorrect product strength labeling on cartons (blister strips show correct strength). Healthcare practices should advise patients to contact their doctor or pharmacy to verify if their medication is affected and stop using recalled lots immediately.
Action Required
Immediately: Clinical staff should identify patients prescribed Clonazepam Orally Disintegrating Tablets and advise them to contact their pharmacy or visit the FDA website to verify if their medication lot is affected. Instruct affected patients to stop using recalled medication and return it to their pharmacy. Document any patient communications regarding this recall in their medical records.